These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7606918)

  • 1. Endothelial changes in galactose-fed dogs.
    Neuenschwander H; Julia C; Wyman M; Kador PF
    Curr Eye Res; 1995 Apr; 14(4):319-22. PubMed ID: 7606918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.
    Datiles MB; Kador PF; Kashima K; Kinoshita JH; Sinha A
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs.
    Kador PF; Takahashi Y; Akagi Y; Neuenschwander H; Greentree W; Lackner P; Blessing K; Wyman M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1916-21. PubMed ID: 12036999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
    Frank RN; Amin R; Kennedy A; Hohman TC
    Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactose-induced retinal microangiopathy in rats.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent retinal capillary pericyte degeneration in galactose-fed dogs.
    Kador PF; Takahashi Y; Akagi Y; Blessing K; Randazzo J; Wyman M
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):63-9. PubMed ID: 17341153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Neuenschwander H; Takahashi Y; Kador PF
    J Ocul Pharmacol Ther; 1997 Dec; 13(6):517-28. PubMed ID: 9436155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.
    Kador PF; Akagi Y; Takahashi Y; Ikebe H; Wyman M; Kinoshita JH
    Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aldose reductase inhibitors on the progression of retinopathy in galactose-fed dogs.
    Akagi Y; Kador PF
    Exp Eye Res; 1990 Jun; 50(6):635-9. PubMed ID: 2115453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective pericyte degeneration in the retinal capillaries of galactose-fed dogs results from apoptosis linked to aldose reductase-catalyzed galactitol accumulation.
    Murata M; Ohta N; Fujisawa S; Tsai JY; Sato S; Akagi Y; Takahashi Y; Neuenschwander H; Kador PF
    J Diabetes Complications; 2002; 16(5):363-70. PubMed ID: 12200082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors.
    Kador PF; Akagi Y; Terubayashi H; Wyman M; Kinoshita JH
    Arch Ophthalmol; 1988 Aug; 106(8):1099-102. PubMed ID: 3401138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors.
    Jacot JL; Hosotani H; Glover JP; Lois N; Robison WG
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):169-80. PubMed ID: 9572543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aldose reductase inhibitors and galactose withdrawal on fluorescein angiographic lesions in galactose-fed dogs.
    Cusick M; Chew EY; Ferris F; Cox TA; Chan CC; Kador PF
    Arch Ophthalmol; 2003 Dec; 121(12):1745-51. PubMed ID: 14662595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cataract development in 12-month-old rats fed a 25% galactose diet and its relation to osmotic stress and oxidative damage.
    Ohta Y; Yamasaki T; Niwa T; Goto H; Majima Y; Ishiguro I
    Ophthalmic Res; 1999; 31(5):321-31. PubMed ID: 10420116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effect of vitamin E-containing liposome instillation on cataract progression in 12-month-old rats fed a 25% galactose diet.
    Ohta Y; Yamasaki T; Niwa T; Majima Y
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):323-35. PubMed ID: 10977128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous flow in galactose-fed dogs.
    Toris CB; Lane JT; Akagi Y; Blessing KA; Kador PF
    Exp Eye Res; 2006 Oct; 83(4):865-70. PubMed ID: 16797006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aldose reductase inhibitor on corneal epithelial barrier function in galactose-fed dogs.
    Kubo E; Mori K; Kobayashi T; Takahashi Y; Yokoi N; Kinoshita S; Kasahara T; Yonezawa H; Akagi Y
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):181-90. PubMed ID: 9572544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose.
    Kador PF; Betts D; Wyman M; Blessing K; Randazzo J
    Am J Vet Res; 2006 Oct; 67(10):1783-7. PubMed ID: 17014334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase inhibitor counteracts the enhanced expression of matrix metalloproteinase-10 and improves corneal wound healing in galactose-fed rats.
    Takamura Y; Matsumoto T; Tomomatsu T; Matsumura T; Takihara Y; Inatani M
    Mol Vis; 2013; 19():2477-86. PubMed ID: 24339723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of retinal vessel changes in galactose-fed dogs.
    Takahashi Y; Augustin W; Wyman M; Kador PF
    J Ocul Pharmacol; 1993; 9(3):257-69. PubMed ID: 8228533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.